Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Harmony Biosciences Holdings (HRMY) Assets Average (2020 - 2025)

Harmony Biosciences Holdings' Assets Average history spans 6 years, with the latest figure at $1.2 billion for Q4 2025.

  • For Q4 2025, Assets Average rose 28.67% year-over-year to $1.2 billion; the TTM value through Dec 2025 reached $1.2 billion, up 28.67%, while the annual FY2025 figure was $1.1 billion, 25.42% up from the prior year.
  • Assets Average for Q4 2025 was $1.2 billion at Harmony Biosciences Holdings, up from $1.2 billion in the prior quarter.
  • Across five years, Assets Average topped out at $1.2 billion in Q4 2025 and bottomed at $348.5 million in Q2 2021.
  • The 5-year median for Assets Average is $753.3 million (2023), against an average of $736.3 million.
  • The largest annual shift saw Assets Average increased 10.36% in 2021 before it skyrocketed 59.77% in 2022.
  • A 5-year view of Assets Average shows it stood at $412.3 million in 2021, then surged by 59.77% to $658.7 million in 2022, then rose by 20.64% to $794.6 million in 2023, then grew by 21.28% to $963.7 million in 2024, then rose by 28.67% to $1.2 billion in 2025.
  • Per Business Quant, the three most recent readings for HRMY's Assets Average are $1.2 billion (Q4 2025), $1.2 billion (Q3 2025), and $1.1 billion (Q2 2025).